The SORAYA study (NCT04296890), which exclusively enrolled FRα‐high patients, consisted of 106 individuals with high‐grade serous ovarian cancer, primary peritoneal cancer, or fallopian tube cancer. This evidence concerns the gene FOLR1 and fallopian tube cancer.